NEULASTIM

Serial Number 86238825
606

Registration Progress

Application Filed
Apr 1, 2014
Under Examination
Aug 12, 2014
Approved for Publication
Jun 17, 2014
Published for Opposition
Jun 17, 2014
Registered

Trademark Image

NEULASTIM

Basic Information

Serial Number
86238825
Filing Date
April 1, 2014
Published for Opposition
June 17, 2014
Abandonment Date
September 18, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 18, 2017
Classes
005

Rights Holder

Amgen Inc.

03
Address
One Amgen Center Drive
Thousand Oaks, CA 913201799

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
Mark I. Feldman, Christina L. Martini

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Sep 18, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 18, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 9, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2017 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 27, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2017 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 23, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 20, 2016 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 4, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 4, 2016 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 24, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 23, 2016 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 2, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 2, 2016 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 5, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 4, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 4, 2015 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 17, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 17, 2015 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 13, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2015 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 11, 2015 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 12, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 17, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 17, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 28, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 10, 2014 ALIE A ASSIGNED TO LIE Loading...
May 10, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 25, 2014 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 25, 2014 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 25, 2014 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 25, 2014 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 25, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 24, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 24, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 24, 2014 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 14, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 4, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceuticals for use in stimulating white blood cell production
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "NEULASTIM" has no meaning in a foreign language.

Classification

International Classes
005